(CFBI) – Litigation
-
Can-Fite BioPharma (CANF) Announces Namodenoson’s Treatment of Liver Fibrosis Receives Notice of Allowance from U.S. Patent Office
-
Can-Fite BioPharma (CANF) NASH Patents Granted and Allowed in Japan, Hong Kong, and Mexico
-
-
-
-
-
-
Back to CFBI Stock Lookup